XS
AZN icon

XR Securities’s AstraZeneca AZN Stock Holding History

XR Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,050
Closed -$15K – 360
2021
Q4 		$15K Buy
11,050
+4,700
+74% +$553K ﹤0.01% 386
2021
Q3 		$12K Buy
+6,350
New +$739K 0.01% 358
2021
Q2 		– Sell
-7,300
Closed -$58K – 430
2021
Q1 		$58K Sell
7,300
-5,400
-43% -$543K ﹤0.01% 332
2020
Q4 		$96K Buy
12,700
+6,250
+97% +$662K 0.01% 250
2020
Q3 		$30K Buy
+6,450
New +$717K ﹤0.01% 205

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XR Securities's AZN Position: Q1 2023 in Review

XR Securities sold out of AstraZeneca (AZN) in Q1 2023, closing a stake of 1,688 shares — an estimated $229K sold.

XR Securities first reported a position in AZN in Q1 2020 and held it in 9 quarters. The position peaked at $1.36M in Q4 2020. 1,056 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

  • XR Securities reported no remaining AstraZeneca position as of Q1 2023 after selling out during the quarter.
  • XR Securities sold 1,688 AstraZeneca shares in Q1 2023, an estimated $229K.
  • XR Securities first reported a position in AstraZeneca in Q1 2020 and held it in 9 quarters.
  • XR Securities's AstraZeneca position peaked at $1.36M in Q4 2020.
  • 1,056 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on XR Securities's 13F filing for Q1 2023, filed 2 May 2023.